Showing results (21-30 of 871) with videos related to
Sort By:
Pageof 88
Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.Journal of Neural Transmission|January 1, 1975
The nature of inhibition of cat brain mitochondrial monoamine oxidase by clorgylineM B Youdim, B HolmanCellular and Molecular Biology (Noisy-Le-Grand, France)|June 29, 2000
The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate systemM B Youdim, S YehudaCellular and Molecular Biology (Noisy-Le-Grand, France)|June 30, 2000
Iron involvement in neural damage and microgliosis in models of neurodegenerative diseasesS Shoham, M B YoudimJournal of Neural Transmission. Supplementum|January 1, 1993
The role of iron in senescence of dopaminergic neurons in Parkinson's diseaseM B Youdim, P RiedererThe British Journal of Psychiatry : the Journal of Mental Science|May 1, 1983
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluationJ Mendlewicz, M B YoudimJournal of Affective Disorders|June 1, 1980
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illnessJ Mendlewicz, M B YoudimBritish Journal of Pharmacology|August 1, 1973
The oestrous cycle and monoamine oxidase activityM Holzbauer, M B YoudimJournal of Neurochemistry|May 1, 1986
Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenylP Riederer, M B YoudimBritish Journal of Pharmacology|November 1, 1985
Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidaseE Melamed, M B YoudimPageof 88